Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue

被引:13
作者
Ro, Y
Muramatsu, T
Shima, K
Yajima, Y
Shibahara, T
Noma, H
Shimono, M
机构
[1] Tokyo Dent Coll, Dept Pathol, Mihama Ku, Chiba 2618502, Japan
[2] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Mihama Ku, Chiba 2618502, Japan
关键词
squamous cell carcinoma; syndecan-1; immunohistochemistry; tongue; biomarker;
D O I
10.1016/j.ijom.2005.06.020
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
We examined expression of syndecan-1 in squamous cell carcinoma (SCC) of tongue using immunohistochemistry. Forty-three cases of SCC arising in lateral border of tongue were investigated. From the immunohistochemical staining pattern, the cases were divided into two groups based on expression of syndecan-1 at the supra-peripheral cells of the tumor nest: Group A, completely or mainly positive; Group B, sporadically positive or negative. Most poorly differentiated SCC cases were classified into Group B (81.8%). The number of Group B cases in T1-2 was different from that in T3-4. The number of cases where syndecan-1 expression was reduced was much greater in T3-4, and represented the majority of Group B (86.7%). More than 80% of Grade 4D cases were in Group B (83.3%) based on the Yamamoto-Kohama criteria. These results indicate that reduction of syndecan-1 correlates to histological grade, tumor size and mode of invasion in tongue SCC.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 32 条
[1]   Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis [J].
Alevizos, I ;
Mahadevappa, M ;
Zhang, X ;
Ohyama, H ;
Kohno, Y ;
Posner, M ;
Gallagher, GT ;
Varvares, M ;
Cohen, D ;
Kim, D ;
Kent, R ;
Donoff, RB ;
Todd, R ;
Yung, CM ;
Warrington, JA ;
Wong, DTW .
ONCOGENE, 2001, 20 (43) :6196-6204
[2]   Syndecan-1 expression has prognostic significance in head and neck carcinoma [J].
Anttonen, A ;
Kajanti, M ;
Heikkilä, P ;
Jalkanen, M ;
Joensuu, H .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :558-564
[3]   High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery [J].
Anttonen, A ;
Heikkilä, P ;
Kajanti, M ;
Jalkanen, M ;
Joensuu, H .
LUNG CANCER, 2001, 32 (03) :297-305
[4]   BIOLOGY OF THE SYNDECANS - A FAMILY OF TRANSMEMBRANE HEPARAN-SULFATE PROTEOGLYCANS [J].
BERNFIELD, M ;
KOKENYESI, R ;
KATO, M ;
HINKES, MT ;
SPRING, J ;
GALLO, RL ;
LOSE, EJ .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :365-393
[5]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[6]   Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer [J].
Ikebe, T ;
Shinohara, M ;
Takeuchi, H ;
Beppu, M ;
Kurahara, S ;
Nakamura, S ;
Shirasuna, K .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (04) :315-323
[7]   ASSOCIATION BETWEEN SYNDECAN-1 EXPRESSION AND CLINICAL OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
INKI, P ;
JOENSUU, H ;
GRENMAN, R ;
KLEMI, P ;
JALKANEN, M .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :319-323
[8]  
INKI P, 1991, AM J PATHOL, V139, P1333
[9]   The role of syndecan-1 in malignancies [J].
Inki, P ;
Jalkanen, M .
ANNALS OF MEDICINE, 1996, 28 (01) :63-67
[10]   IMMUNOHISTOCHEMICAL LOCALIZATION OF SYNDECAN-1 IN NORMAL AND PATHOLOGICAL HUMAN UTERINE CERVIX [J].
INKI, P ;
STENBACK, F ;
GRENMAN, S ;
JALKANEN, M .
JOURNAL OF PATHOLOGY, 1994, 172 (04) :349-355